The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central α1-adrenergic system in rats

Behavioural Pharmacology

Volumn 15, Issue 2, 2004, Pages 159-165

  Dziedzicka Wasylewska, M ^a   Faron Gorecka A ^a   Rogoz Z ^a   Solich, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1 adrenergic receptor; Adaptive changes; Amantadine; Imipramine; Mouse; Rat; Repeated treatment

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; AMANTADINE; CLONIDINE; DEXAMPHETAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; IMIPRAMINE; PHENYLEPHRINE; PRAZOSIN;

ADRENERGIC SYSTEM; AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CONTROLLED STUDY; DENSITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; FOLLOW UP; HYPERACTIVITY; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; AGGRESSION; AMANTADINE; AMPHETAMINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; CEREBRAL CORTEX; CLONIDINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EXPLORATORY BEHAVIOR; HYPERKINESIS; IMIPRAMINE; MALE; MOTOR ACTIVITY; PHENYLEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 2342517347     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200403000-00008     Document Type: Article

References (38)

1. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. (2000). Antidepressant effects of ketamine in the depressed patients. Biol Psychiatry 47:351-354.
2. Blanc G, Trovero F, Vezina P, Hervė D, Godehen A-M, Glowinski J, et al. (1994). Blockade of prefronto-cortical α1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 6:293-298.
3. D'Aquila PS, Collu M, Gessa GL, Serra G (2000). The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405:365-373.
4. Darracq L, Blanc G, Glowinski J, Tassin JP (1998). Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18:2729-2739.
5. De Paermentier F, Manger JM, Lowther S, Crompton MR, Katona CL, Horton RW (1997). Brain alpha-adrenoceptors in depressed suicides. Brain Res 757:60-67.
6. 2 dopamine receptors in the rat brain. J Neural Transm 104:515-524.
7. 3H]7-OH-DPAT to dopamine receptors in peripheral blood lymphocytes of the patients with drug-resistant unipolar depression. Pol J Pharmacol 54:703-706.
8. 1- adrenoceptors in the frontal cortex of the rat. Neuropsychopharmacology 31:955-960.
9. Heal DJ (1984). Phenylephrine-induced activity in mice as a model of central α1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock. Neuropharmacology 23:1242-1251.
10. Huber TJ, Dietrich DE, Emrich HM (1999). Possible use of amantadine in depression. Pharmacopsychiatry 32:47-55.
11. Kelly PM, Seviour PW, Iversen SD (1975). Amphetamine and apomorphine responses in the rat folowing 6-hydroxydopamine lesions at the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522.
12. Kolasiewicz W, Maj J (1996). Locomotor activity and motor disturbances induced by the competitive antagonist CGP37849. Pol J Pharmacol 48:467-478.
13. 3 receptor gene expression as a common effect of chronic antidepressant treatments. Mol Psychiatry 5:378-388.
14. Maj J (1991). Antidepressants given repeatedly: pharmacological evaluation of their action. Pol J Pharmacol 43:241-254.
15. Maj J, Rogóż Z (2000). Synergistic effect of amantadine and imipramine in the forced swimming test. Pol J Pharmacol 52:111-114.
16. Maj J, Mogilnicka E, Klimek V, Kordecka-Magiera A (1981). Chronic treatment with antidepressants: potentiation of clonidine-induced aggression in mice via noradrenergic mechanism. J Neural Transm 52:189-197.
17. 3 receptors in the rat brain. Eur J Pharmacol 351:31-37.
18. 1- adrenergic, dopaminergic and seronergic receptors in rat brain. Hum Psychopharmacol Clin Exp 14:333-334.
19. 2A systems. J Neural Transm 107:1345-1359.
20. Mathews R, Li PP, Young LT, Kish SJ, Warsh JJ (1997). Increased Galphaq/11 immunoreactivity in post mortem occipital cortex from patients with bipolar affective disorder. Biol Psychiatry 41:649-656.
21. 1-adrenoceptor. Eur J Pharmacol 87:35-41.
22. Nelson MR, Dunner DL (1993). Treatment resistance in unipolar depression and other disorders. Psychiatr Clin North Am 16:541-566.
23. Ozawa H, Miyauchi T, Sugawara K (1975). Potentiating effect of lithium chloride on aggressive behaviour induced in mice by nialamide plus L-DOPA and by clonidine. Eur J Pharmacol 34:169-179.
24. Pijnenburg AJ, Honig WM, Van Rossum JM (1975). Inhibition of o-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat. Psychopharmacology 41:87-95.
25. Paxinos G, Watson C (1986). The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
26. 3 receptors in the rat brain differentiated by agonist and antagonist binding - an autoradiographic analysis. Naunyn Schmiedeberg's Arch Pharmacol 359:178-186.
27. 1-adrenergic system. Neuropharmacology 41:360-368.
28. 1-adrenergic and dopaminergic receptors. Pol J Pharmacol 54:593-603.
29. 1-adrenergic receptors. J Physiol Pharmacol 53:105-116.
30. Rogóż Z, Skuza G, Kusmider M, Maj J, Danysz W (2002c). Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 42:1024-1030.
31. 3 receptors in rats. J Physiol Pharmacol 54:257-270.
32. Rogóż Z, Skuza G, Wójcikowski J, Kot M, Daniel WA (2004). Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies. Pol J Pharmacol (in press).
33. Sourey D, Amsterdam J, De Montigny C, Lecrubier Y, Montgomery S, Lipp O, et al. (1999). Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol 9:83-91.
34. Stockmeier CA, McLeskey SW, Blendy JA, Armstrong NR, Kellar KJ (1987). Electroconvulsive shock but not antidepressant drugs increases α1-adrenoceptor binding sites in rat brain. Eur J Pharmacol 139:259-266.
35. Stone EA, Lin Y, Rosengarten H, Kramer HK, Quartermain D (2003). Emerging evidence for a central epinephrine-innervated α1-adrenergic system that regulates behavioral activation and is impaired in depression. Neuropsychopharmacology 28:1387-1399.
36. Stryjer R, Strous RD, Shaked G, Bar F, Feldman B, Kotler M, et al. (2003). Amantadine as augmentation therapy in the management of treatment-resistant depression. Int Clin Psychopharmacol 18:93-96.
37. Vetulani J, Nalepa I (2000). Antidepressants: past, present and future. Eur J Pharmacol 405:351-363.
38. Willner P (1997). The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol 12(suppl 3):S7-S14.